NASDAQ:OBLN - Obalon Therapeutics Price Target & Analyst Ratings

$0.68
-0.11 (-13.92 %)
(As of 06/17/2019 03:35 AM ET)
Today's Range
$0.6507
Now: $0.68
$0.80
50-Day Range
$0.39
MA: $0.72
$1.4267
52-Week Range
$0.37
Now: $0.68
$3.70
Volume2.43 million shs
Average Volume13.67 million shs
Market Capitalization$16.32 million
P/E RatioN/A
Dividend YieldN/A
Beta-5.12

Analyst Ratings

Obalon Therapeutics (NASDAQ:OBLN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Obalon Therapeutics in the last 12 months. Their average twelve-month price target is $2.35, suggesting that the stock has a possible upside of 245.59%. The high price target for OBLN is $3.50 and the low price target for OBLN is $1.00. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldBuyBuy
Consensus Rating Score: 2.402.402.502.60
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $2.35$2.35$2.8125$5.10
Price Target Upside: 245.59% upside327.27% upside31.43% upside54.55% upside

Obalon Therapeutics (NASDAQ:OBLN) Consensus Price Target History

Price Target History for Obalon Therapeutics (NASDAQ:OBLN)

Obalon Therapeutics (NASDAQ:OBLN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/11/2019Northland SecuritiesReiterated RatingHold$1.00LowView Rating Details
4/8/2019Canaccord GenuityDowngradeBuy ➝ Hold$3.00 ➝ $1.50HighView Rating Details
2/26/2019Roth CapitalReiterated RatingBuy ➝ Neutral$6.00 ➝ $2.75HighView Rating Details
2/25/2019Stifel NicolausUpgradeHold ➝ Buy$2.50 ➝ $3.00HighView Rating Details
9/12/2018BTIG ResearchReiterated RatingBuy$3.50LowView Rating Details
11/10/2017UBS GroupLower Price TargetBuy$20.00 ➝ $16.00N/AView Rating Details
(Data available from 6/17/2017 forward)
This page was last updated on 6/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel